A wide field path winds through the countryside in warm evening light, with people walking in the distance.

The disease

What do I have? Lung cancer and NSCLC explained

Your report may say things like “NSCLC”, “adenocarcinoma” or “stage IV”. Here is what these words mean.

  • 4 min read
  • Updated 17 November 2026

Most important in brief

  • NSCLC means non-small cell lung cancer. It is the most common form of lung cancer.
  • The stage and the features of the tumour (biomarkers) decide which treatment is suitable.
  • The form of NSCLC, usually adenocarcinoma or squamous cell carcinoma, helps decide which tests and which chemo fit.
  • In stages I to III the aim is usually cure; in stage IV, treatment goes line by line.
  • Small cell lung cancer is a different disease and has its own page.

What is lung cancer, and what is NSCLC?

Lung cancer starts when cells in the lung grow out of control. Doctors divide it into two main groups: small cell and non-small cell lung cancer. The second group is called NSCLC, short for “non-small cell lung cancer”.

NSCLC is the more common form. According to the American Cancer Society, about 80 to 85 in every 100 lung cancers are NSCLC. Types of NSCLC include adenocarcinoma and squamous cell carcinoma. Your type is written in the pathology report.

This page mainly explains non-small cell lung cancer. Small cell lung cancer is a different disease, often grows faster and is treated differently. It has its own page: Small cell lung cancer.

Which form of NSCLC?

Under the microscope, pathologists mainly tell two forms apart: adenocarcinoma, the most common, and squamous cell carcinoma. The form is written in the report. It matters for two reasons.

Changes such as EGFR, ALK or ROS1 are found almost only in adenocarcinoma. And some chemo medicines only fit one form; pemetrexed, for example, only fits adenocarcinoma (chemotherapy).

What does the stage mean?

The stage describes how far the disease has spread. It comes from CT, PET-CT, a brain MRI and sometimes a sample from the lymph nodes. Simplified:

  • Stage I: a small tumour, no affected lymph nodes.
  • Stage II: a larger tumour or affected lymph nodes close to the lung.
  • Stage III: affected lymph nodes in the middle of the chest, or the tumour grows into nearby organs. Chemo and radiotherapy are then often given together instead of surgery.
  • Stage IV: spread to other organs, or fluid around the lung.

In stages I to III the aim is usually cure, with surgery or radiotherapy, often with medicines before or after.

In stage IV, treatment is usually given line by line with medicines that work throughout the body (Treatment). Your care team will tell you your stage. Small cell lung cancer is divided differently: limited or extensive.

What is inside the tumour: biomarkers

Not every lung cancer is the same. With NSCLC, the tumour is tested for specific changes, for example EGFR, ALK, ROS1 or KRAS G12C, and for the protein PD-L1. For many of these changes there are medicines aimed directly at them. What each result means is explained under Your test result.

These changes arise in the tumour itself. They are usually not inherited. EGFR, ALK and ROS1 and KRAS G12C have their own pages; all others are under Rarer changes.

Words you may hear

NSCLC
Non-small cell lung cancer, the most common form of lung cancer.
Adenocarcinoma
The most common form of NSCLC. Changes such as EGFR or ALK are found almost only here.
Squamous cell carcinoma
The second main form of NSCLC, more common in smokers. It helps decide the chemo partners.
Small cell lung cancer (SCLC)
About 15 in 100 lung cancers. Often grows faster and is treated differently.
Limited / extensive
The two stages of small cell lung cancer: whether everything fits in one radiotherapy field or not.
Biomarker
A measurable feature of the tumour that helps guide treatment.
Mutation
A change in a gene, for example EGFR or KRAS G12C. In lung cancer it usually arises in the tumour itself.
Gene fusion
Two genes have fused and send a constant signal, for example ALK or ROS1.
PD-L1 (TPS)
A protein on tumour cells, given as a percentage. From 50%, immunotherapy alone may be an option; below that, usually with chemo.
NGS
Next-generation sequencing: a test that looks at many genes at once.
Biopsy
Taking a small sample of tissue.
Stage
How far the disease has spread, from I to IV.
Metastases
Places where the cancer has spread to other parts of the body.
Tumour board
Doctors from different specialties discuss your case together.
Neoadjuvant / adjuvant
Treatment before surgery (neoadjuvant) or after it (adjuvant), so the cancer does not come back.
Chemoradiotherapy
Chemo and radiotherapy at the same time, mainly in stage III.
SBRT
Very precise, high-dose radiotherapy in a few sessions, for a small tumour.
PCI
Preventive radiotherapy of the brain, mainly in small cell lung cancer.
Line of treatment
First-line is the first treatment for advanced disease. Second-line follows if the first stops working or is not tolerated.
Maintenance
After the first cycles, part of the treatment is continued on its own for as long as it works.

Sources

  1. American Cancer Society: What is lung cancer?
  2. ESMO Patient Guide: Small cell lung cancer

All sources last checked on 12 November 2026, unless another date is given.